PRDM9 and glioblastoma: This is, for instance, reflected in the tissue-specific involvement of the histone methyltransferase in tumor-promoting (e.g., PDAC, glioblastoma [15,43]) vs. tumor-suppressive (e.g., colorectal cancer [44]) programs.